A

Amphastar Pharmaceuticals
D

AMPH

31.260
USD
-0.07
(-0.22%)
Market Closed
Volume
17,900
EPS
0
Div Yield
-
P/E
10
Market Cap
1,503,025,596
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    -0.635
    (-4.00%)
    15.225 USD
    A
    AIT
    -18.130
    (-6.87%)
    245.700 USD
    A
    ALK
    -5.140
    (-6.82%)
    70.210 USD
    BA
    BA
    -3.550
    (-1.96%)
    177.320 USD
    DAL
    DAL
    -3.770
    (-5.91%)
    59.980 USD
    HEI
    HEI
    -0.020
    (-0.01%)
    225.560 USD
    L
    LUV
    -0.805
    (-2.63%)
    29.800 USD
    TDG
    TDG
    -22.91
    (-1.75%)
    1,289.99 USD
    U
    UAL
    -6.540
    (-6.38%)
    95.930 USD
    More
News

Title: Amphastar Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has tworeportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.